Nexalin Technology, Inc. Cost of Revenue
Nexalin Technology, Inc. (NXL) reported Cost of Revenue of $3.26 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-12
- Nexalin Technology, Inc. cost of revenue for the quarter ending 2026-06-30 was $3.26K, a 85.71% decline year-over-year.
- Nexalin Technology, Inc. cost of revenue for the quarter ending 2026-03-31 was $1.82K, a 86.60% decline year-over-year.
- Nexalin Technology, Inc. cost of revenue for the quarter ending 2025-12-31 was $21.03K, a 180.54% increase year-over-year.
- Nexalin Technology, Inc. cost of revenue for the quarter ending 2025-09-30 was $3.95K, a 68.90% decline year-over-year.
- Nexalin Technology, Inc. cost of revenue for fiscal 2025 was $61.37K, a 67.72% increase from fiscal 2024.
- Nexalin Technology, Inc. cost of revenue for fiscal 2024 was $36.59K, a 42.45% increase from fiscal 2023.
- Nexalin Technology, Inc. cost of revenue for fiscal 2023 was $25.69K, a 92.93% decline from fiscal 2022.
- Nexalin Technology, Inc. cost of revenue for fiscal 2022 was $363.21K, a 1593.93% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.26K 10-Q · filed 2026-08-12 | $5.08K 10-Q · filed 2026-08-12 | $26.11K derived: sum of 3 quarters · filed 2026-08-12 | $30.06K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $1.82K 10-Q · filed 2026-05-08 | $22.85K derived: sum of 2 quarters · filed 2026-05-08 | $26.79K derived: sum of 3 quarters · filed 2026-05-08 | $49.63K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $21.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $24.98K derived: sum of 2 quarters · filed 2026-03-25 | $47.81K derived: sum of 3 quarters · filed 2026-08-12 | $61.37K 10-K · filed 2026-03-25 |
| 2025-09-30 | $3.95K 10-Q · filed 2025-11-14 | $26.79K derived: sum of 2 quarters · filed 2026-08-12 | $40.34K 10-Q · filed 2025-11-14 | $47.84K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $22.84K 10-Q · filed 2026-08-12 | $36.40K 10-Q · filed 2026-08-12 | $43.89K derived: sum of 3 quarters · filed 2026-08-12 | $56.59K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $13.56K 10-Q · filed 2026-05-08 | $21.05K derived: sum of 2 quarters · filed 2026-05-08 | $33.75K derived: sum of 3 quarters · filed 2026-05-08 | $40.99K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $7.50K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $20.19K derived: sum of 2 quarters · filed 2026-03-25 | $27.44K derived: sum of 3 quarters · filed 2026-03-25 | $36.59K 10-K · filed 2026-03-25 |
| 2024-09-30 | $12.69K 10-Q · filed 2025-11-14 | $19.94K derived: sum of 2 quarters · filed 2025-11-14 | $29.10K 10-Q · filed 2025-11-14 | $34.33K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $7.25K 10-Q · filed 2025-08-06 | $16.40K 10-Q · filed 2025-08-06 | $21.63K derived: sum of 3 quarters · filed 2025-09-23 | $25.61K derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-03-31 | $9.16K 10-Q · filed 2025-05-13 | $14.39K derived: sum of 2 quarters · filed 2025-09-23 | $18.36K derived: sum of 3 quarters · filed 2025-09-23 | $27.73K derived: sum of 4 quarters · filed 2025-09-23 |
| 2023-12-31 | $5.23K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23 | $9.20K derived: sum of 2 quarters · filed 2025-09-23 | $18.58K derived: sum of 3 quarters · filed 2025-09-23 | $25.69K 10-K/A · filed 2025-09-23 |
| 2023-09-30 | $3.97K 10-Q · filed 2024-11-08 | $13.35K derived: sum of 2 quarters · filed 2024-11-08 | $20.46K 10-Q · filed 2024-11-08 | $27.32K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $9.37K 10-Q · filed 2024-08-08 | $16.48K 10-Q · filed 2024-08-08 | $23.35K derived: sum of 3 quarters · filed 2024-08-08 | $210.65K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $7.11K 10-Q · filed 2024-05-10 | $13.98K derived: sum of 2 quarters · filed 2024-05-10 | $201.28K derived: sum of 3 quarters · filed 2024-05-10 | $324.31K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $6.87K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $194.16K derived: sum of 2 quarters · filed 2024-03-27 | $317.20K derived: sum of 3 quarters · filed 2024-03-27 | $363.21K 10-K · filed 2024-03-27 |
| 2022-09-30 | $187.30K 10-Q · filed 2023-11-13 | $310.33K derived: sum of 2 quarters · filed 2023-11-13 | $356.35K 10-Q · filed 2023-11-13 | $355.34K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $123.03K 10-Q · filed 2023-08-10 | $169.05K 10-Q · filed 2023-08-10 | $168.04K derived: sum of 3 quarters · filed 2023-08-10 | $177.35K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $46.02K 10-Q · filed 2023-05-10 | $45.01K derived: sum of 2 quarters · filed 2023-05-10 | $54.31K derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$1.01K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $8.30K derived: sum of 2 quarters · filed 2023-03-27 | $21.44K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $9.31K 10-Q · filed 2022-11-10 | $22.45K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |